Treatment of ErbB2 breast cancer by mitochondrial targeting

Cancer & Metabolism
Sophia EldadJacob Bar-Tana

Abstract

ErbB2 breast cancer still remains an unmet need due to primary and/or acquired resistance to current treatment strategies. MEDICA compounds consist of synthetic long-chain α,ω-dicarboxylic acids previously reported to suppress breast cancer in PyMT transgenic mice. MEDICA efficacy and mode of action in the ErbB2 context was studied in ErbB2 transgenic mice and human breast cancer cells. MEDICA treatment is shown here to suppress ErbB2 breast tumors and lung metastasis in ErbB2/neu MMTV transgenic mice, to suppress ErbB2/neu xenografts in nod/scid mice, and to suppress survival of AU565 and BT474 human ErbB2 breast cancer cells. Suppression of ErbB2 breast tumors by MEDICA is due to lipid raft disruption with loss of ErbB family members, including EGFR, ErbB2, and ErbB3. In addition, MEDICA inhibits mTORC1 activity, independently of abrogating the ErbB receptors and their signaling cascades. The double hit of MEDICA in abrogating ErbB and mTORC1 is partly accounted for by targeting mitochondria complex I. Mitochondrial targeting by MEDICA suppresses ErbB2 breast tumors and metastasis due to lipid raft disruption and inhibition of mTORC1 activity. Inhibition of mTORC1 activity by MEDICA avoids the resistance acquired by canonical...Continue Reading

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·C T GuyW J Muller
Feb 3, 2006·Cancer Research·Kathryn E O'ReillyNeal Rosen
Oct 12, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hani AtamnaBruce N Ames
Nov 27, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Philippe NourissatOdile Sergent
Sep 25, 2008·Biochemical Pharmacology·Ghadeer Za'taraRachel Hertz
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sao JiralerspongAna M Gonzalez-Angulo
May 24, 2011·Diabetes·Ghadeer ZataraJacob Bar-Tana
Nov 25, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·X HeS-C J Yeung
Dec 6, 2011·Cancer Discovery·Vanessa S Rodrik-OutmezguineNeal Rosen
Feb 18, 2012·Journal of Lipid Research·Bella KalderonJacob Bar-Tana
May 12, 2012·Cancer Discovery·Sarat Chandarlapaty
Sep 22, 2012·British Journal of Cancer·P BoyleP Autier
Apr 11, 2013·Endocrine-related Cancer·Rosalyn D FergusonDerek LeRoith
Jul 19, 2013·Biochemical Society Transactions·Jessica J HowellBrendan D Manning
May 21, 2014·ELife·William W WheatonNavdeep S Chandel
Jun 18, 2014·Nature Reviews. Endocrinology·Jiyoung ParkPhilipp E Scherer
Oct 12, 2014·Cancer Research·Udi GluschnaiderJacob Bar-Tana
Nov 29, 2015·Seminars in Oncology·Elisa ZanardiSerena Di Cosimo
Feb 13, 2016·Nature Communications·Constantinos DemetriadesAurelio A Teleman
Mar 10, 2016·Oncotarget·Rawan AtiqJacob Bar-Tana
Feb 15, 2017·Journal of Experimental & Clinical Cancer Research : CR·Amanda B ParrisXiaohe Yang
Mar 9, 2017·American Journal of Physiology. Endocrinology and Metabolism·Michael ValitskyJacob Bar-Tana
Mar 12, 2017·Cell·Robert A Saxton, David M Sabatini
Apr 5, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amir SonnenblickEvandro de Azambuja
Apr 15, 2017·Oncotarget·Reza Bayat MokhtariHerman Yeger
Jul 18, 2017·Cancer Treatment Reviews·Sagun ParakhAndrew M Scott
Feb 11, 2018·Cellular and Molecular Life Sciences : CMLS·Ana L Santos, Giulio Preta
Jun 27, 2018·Nature Cell Biology·Lucas B SullivanMatthew G Vander Heiden
Jun 27, 2018·Nature Cell Biology·Javier Garcia-BermudezKıvanç Birsoy
Sep 15, 2018·Endocrinology·Chifei KangEmily J Gallagher

❮ Previous
Next ❯

Citations

Mar 14, 2021·Scientific Reports·Yana AisenJacob Bar-Tana

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
FACS
confocal microscopy
FCS
PCR
density gradient centrifugation
xenografts

Software Mentioned

MEDICA
GraphPad

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Michael P DiGiovannaAnn D Thor
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
F RévillionJ P Peyrat
American Journal of Clinical Pathology
D C Allred, P E Swanson
© 2021 Meta ULC. All rights reserved